Interview with Ikeura, President and CEO of Axcelead, a holding company, was published in “PHARMA JAPAN”. 『Axcelead to Expand Overseas Biz, Shoots for 130 Billion Yen Sales and 5,000-Plus Researchers』

As a global CRDMO (Contract Research, Development and Manufacturing Organization), Axelead, a holding company, will be fully developing its overseas business in the future. Dr. Ikeura answers questions from the media.

（April 13, 2023）

Read full article

PHARMA JAPAN Posted on April 13, 2023
[LICENSE NO. 20230417_02] Jiho Inc. permits the use of articles.